Harvard research funding has recently become a critical battleground as the institution grapples with significant threats to its innovative projects, particularly following the chaotic aftermath of a stop-work order.This order, affecting pivotal organ-on-a-chip projects led by renowned researcher Don Ingber, has sent waves of uncertainty through Harvard’s scientific community.